JPMorgan, Bank of America Merrill Lynch and Raymond James Financial have arranged a $400 million credit facility to help back HealthSprings acquisition of Bravo Health, according to sources.
The firm, whose deals have included healthcare software provider EMIS and mining house Vallar, says further transactions are in the pipeline.
Two years of digging for opportunities on the subcontinent results in the PE firm backing one of Indias largest chains of pathology laboratories.
Term loan B is backing the merger between Valeant Pharmaceuticals and Biovail.
Rofsky joins as a managing director in the firms New York office.
Fourteen years ago, Smith Barney veteran Robert Greenhill decided he would only provide advice. It is a formula that resonates with clients today.
These clauses play an important role to bridge the gap between buyers and sellers, but there are tripwires that can sour a deal.
Does an improving market for corporate borrowers to reprice their debt signal a shift in the balance of power to issuers?
IMS Health transactions could serve as a case study for future M&A-related junk bond offerings.
Private-equity group Cerberus Capital Management LP yesterday said it would buy Bostons nonprofit Caritas Christi Health Care for $830 million, taking over the Catholic systems long-term debt and spending $400 million on capital upgrades.